This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vermylen, J. Articles by Amout, J. Search for Related Content PubMed PubMed Citation Articles by Vermylen, J. Articles by Amout, J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Autoimmune Diseases Hazardous Substances DB HEPARIN Social Bookmarking                         What's this?

Review : Antibody-mediated thrombosis: relation to the antiphospholipid syndrome

Center for Molecular and Vascular Biology, University of Leuven, Belgium

C. Van Geet

Center for Molecular and Vascular Biology, University of Leuven, Belgium

J. Amout

Center for Molecular and Vascular Biology, University of Leuven, Belgium

Various forms of antibody-mediated thrombosis are presented and the mechanisms involved in their pathogenesis are discussed. Antibody-mediated thrombosis includes heparin-induced thrombo cytopenia and thrombosis, autoantibodies to von Willebrand factor mimicking an antiphospholipid syndrome, thrombosis following injection of the murine monoclonal antibody OKT3, hyperacute and acute xenograft rejection, and varicella-associated antibody against protein S. In several of these entities the pathogenesis of thrombosis is closely related to development of cellular procoagulant activity through tight occupancy of Fc receptors, or through complement activation, or through cell-cell interactions. Integrating the antiphospholipid syndrome into the more general category of antibody-mediated thrombosis may provide some hints as to how we could approach the study of those intriguing patients who have the clinical features of the antiphospholipid syndrome but lack those antibodies that currently characterize it.

Key Words: heparin-induced thrombocytopenia • von Willebrand factor antibody • OKT3 antibody • xenograft rejection • protein S antibody

Lupus, Vol. 7, No. 2 suppl, S63-S66 (1998)
DOI: 10.1177/096120339800700215


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Raschi, C. Testoni, D. Bosisio, M. O. Borghi, T. Koike, A. Mantovani, and P. L. Meroni Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies Blood, May 1, 2003; 101(9): 3495 - 3500. [Abstract] [Full Text] [PDF]